Morning Market Losers

shares dipped 78.95 percent to $2.88 on the failed CUPID2 trial of MYDICAR in advanced heart failure.

shares declined 18.16 percent to $45.21 following the report of overstatement of revenue and downgrade. The company said it will make additional accounting restatements that will reduce previously reported revenue for the final three quarters of 2014. Piper Jaffray downgraded Akorn from Overweight to Neutral.

slipped 14.64 percent to $38.62. CRT Capital downgraded American Science from Fair Value to Sell.

shares declined 13.89 percent to $38.06. Silicom reported Q1 adjusted earnings of $0.52 per share on revenue of $18.8 million.

shares dropped 12.09 percent to $5.31. Topeka Capital downgraded Merge Healthcare from Buy to Hold.

shares slipped 10.06 percent to $4.29. Accuride reported a Q1 loss of $0.01per share on revenue of $183.7 million.

shares fell 7.34 percent to $20.20 following the announcement of termination of business combination agreement with

.

shares slipped 4.23 percent to $32.81 on the announcement of business strategy. Deutsche Bank will spinoff Postbank branches in Germany via IPO.

shares dropped 1.15 percent to $14.14. Marvell Technology said Q1 revenue will be below its earlier forecast.